Related Experiment Video
Updated: Mar 29, 2026

In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption
Published on: June 20, 2017
Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease
Veronica Galvan1, Matthew J Hart2
1Department of Physiology and the Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio.
Abstract:
Aging is the strongest known risk factor for Alzheimer's disease (AD). With the discovery of the mechanistic target of rapamycin (mTOR) as a critical pathway controlling the rate of aging in mice, molecules at the interface between the regulation of aging and the mechanisms of specific age-associated diseases can be identified. We will review emerging evidence that mTOR-dependent brain vascular dysfunction, a universal feature of aging, may be one of the mechanisms linking the regulation of the rate of aging to the pathogenesis of Alzheimer's disease. This article is part of a Special Issue entitled: Vascular Contributions to Cognitive Impairment and Dementia edited by M. Paul Murphy, Roderick A. Corriveau and Donna M. Wilcock.
Insights
Aging accelerates Alzheimer's disease (AD) risk. The mechanistic target of rapamycin (mTOR) pathway links aging regulation to AD, potentially via brain vascular dysfunction.
Area of Science:
- Neuroscience
- Aging research
- Vascular biology
Background:
- Aging is the primary risk factor for Alzheimer's disease (AD).
- The mechanistic target of rapamycin (mTOR) pathway regulates aging processes.
- Brain vascular dysfunction is a common feature of aging.
Purpose of the Study:
- To explore the link between mTOR-dependent aging regulation and Alzheimer's disease pathogenesis.
- To review evidence on mTOR's role in brain vascular dysfunction as a mediator for AD.
Main Methods:
- Review of emerging scientific literature.
- Analysis of mechanistic target of rapamycin (mTOR) pathway in aging and AD.
- Examination of brain vascular dysfunction as a potential link.
Main Results:
- The mTOR pathway is a key regulator of aging.
- mTOR influences brain vascular function, which declines with age.
- This vascular dysfunction may connect aging processes to Alzheimer's development.
Conclusions:
- mTOR-dependent brain vascular dysfunction is a potential mechanism linking aging to Alzheimer's disease.
- Targeting the mTOR pathway could offer new therapeutic strategies for AD.
- Understanding vascular contributions to AD is crucial for developing effective treatments.
More Related Videos
06:40Isolation and Functional Analysis of Arteriolar Endothelium of Mouse Brain Parenchyma
Published on: March 11, 2022
14:57Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
Related Concept Videos
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Mitochondria
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
The Effect of Aging on Tissues